Analyze Diet
Molecules (Basel, Switzerland)2023; 28(23); 7723; doi: 10.3390/molecules28237723

Cytotoxic Natural Products Isolated from Cryptogramma crispa (L.) R. Br.

Abstract: Parsley fern, , is a common fern in arctic-alpine regions, and even though this species has been known since ancient times and has been presumed to cause the poisoning of horses, its natural products have not previously been investigated. Here, we characterise 15 natural products isolated from the aerial parts of , including the previously undescribed compound 3-malonyl pteroside D. The structure determinations were based on several advanced 1D and 2D NMR spectroscopic techniques, Circular Dichroism spectroscopy and high-resolution mass spectrometry. The pteroside derivatives exhibited selective moderate cytotoxic activity against the acute myeloid leukaemia MOLM13 cell line and no cytotoxicity against the normal heart and kidney cell lines, suggesting that their potential anticancer effect should be further investigated.
Publication Date: 2023-11-23 PubMed ID: 38067454PubMed Central: PMC10708030DOI: 10.3390/molecules28237723Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The research article investigates the natural products derived from Parsley fern, commonly found in arctic-alpine regions. The study identifies and characterizes 15 natural compounds, including a previously unknown compound and investigates their potential anticancer effects by testing their impact on leukaemia and normal cell lines.

Introduction and Research Methodology

  • The research article is centered around the study of Cryptogramma crispa, or Parsley fern. This is a common plant found in arctic-alpine regions and is known to cause horse poisoning.
  • Prior to this research, there had been no investigation of the natural products derived from this plant.
  • What this research does, for the first time, is discover and characterize 15 natural products which originate from the aerial parts of the Parsley fern.
  • The discovery of these compounds included the first ever identification of the compound 3-malonyl pteroside D.
  • The primary techniques used to determine the structure of these compounds included advanced 1D and 2D NMR spectroscopic techniques, Circular Dichroism spectroscopy and high-resolution mass spectrometry.

Investigation of Cytotoxic Activity

  • The isolated compounds were tested for their cytotoxic activity, essentially, their ability to kill cells.
  • More specifically, their effectiveness was tested against the acute myeloid leukaemia MOLM13 cell line. These are a type of cancer cell derived from leukemia patients, frequently used in medical research.
  • The results revealed that the isolated compounds show moderate cytotoxic activity against these malignant cells.
  • However, it is noteworthy that these compounds did not exhibit cytotoxicity against normal heart and kidney cell lines.

Implications and Conclusion

  • The selective cytotoxicity of these compounds suggests potential anticancer applications.
  • The results show promise in the pursuit of new treatments for acute myeloid leukaemia.
  • The authors of the paper argue that this potential anticancer effect warrants further investigation and research.
  • Given the limitations of the study, this research represents an initial step towards understanding the potential medical applications of Compounds derived from Cryptogramma crispa.

Cite This Article

APA
Diaz AEC, Herfindal L, Andersen HL, Fossen T. (2023). Cytotoxic Natural Products Isolated from Cryptogramma crispa (L.) R. Br. Molecules, 28(23), 7723. https://doi.org/10.3390/molecules28237723

Publication

ISSN: 1420-3049
NlmUniqueID: 100964009
Country: Switzerland
Language: English
Volume: 28
Issue: 23
PII: 7723

Researcher Affiliations

Diaz, Andrea Estefania Carpinteyro
  • Department of Chemistry and Centre for Pharmacy, University of Bergen, N-5007 Bergen, Norway.
Herfindal, Lars
  • Department of Clinical Science and Centre for Pharmacy, University of Bergen, N-5009 Bergen, Norway.
Andersen, Heidi Lie
  • University Gardens, University of Bergen, Allégt. 41, N-5007 Bergen, Norway.
Fossen, Torgils
  • Department of Chemistry and Centre for Pharmacy, University of Bergen, N-5007 Bergen, Norway.

Grant Funding

  • 180007 / Norwegian Society for Children's Cancer
  • 190004 / Norwegian Society for Children's Cancer
  • 226244/F50 / The Research Council of Norway

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 27 references
  1. Metzgar J.S., Alverson E.R., Chen S., Vaganov A.V., Ickert-Bond S.M.. Diversification and reticulation in the circumboreal fern genus Cryptogramma.. Mol. Phylogenetics Evol. 2013;67:589–599.
    doi: 10.1016/j.ympev.2013.02.020pubmed: 23454494google scholar: lookup
  2. Veit M., Bilger W., Mühlbauer T., Brummet W., Winter K.. Diurnal Changes in Flavonoids.. J. Plant Physiol. 1996;148:478–482.
  3. Tomaselli M., Petraglia A., Rossi G., Adorni M.. Contribution to the environmental ecology of Cryptogramma crispa (L.) R. Br. ex Hooker in the Alps.. Flora 2005;200:175–186.
  4. Pajaro’n S., Pangua E., Garci´a-A´lvarez L.. Sexual expression and genetic diversity in populations of Cryptogramma crispa (Pteridaceae). Am. J. Bot. 1999;86:964–973.
    doi: 10.2307/2656613pubmed: 10406719google scholar: lookup
  5. Fægri K. Norges Planter: Blomster og Trær i Naturen: Med et Utvalg fra Våre Nabolands Flora: 2. 2nd ed. Volume 2 Cappelen; Oslo, Norway: 1970.
  6. Guo Y., Li J.J., Busta L., Jetter R.. Coverage and composition of cuticular waxes on the fronds of the temperate ferns Pteridium aquilinum, Cryptogramma crispa, Polypodium glycyrrhiza, Polystichum munitum and Gymnocarpium dryopteris.. Ann. Bot. 2018;122:555–568.
    doi: 10.1093/aob/mcy078pmc: PMC6153475pubmed: 30252045google scholar: lookup
  7. Fons F., Froissard D., Morel S., Bessière J.-M., Buatois B., Sol V., Fruchier A., Rapior S.. Pteridaceae Fragrant Resource and Bioactive Potential: A Mini-review of Aroma Compounds.. Nat. Prod. Commun. 2018;13:651–655.
  8. Murakami T., Taguchi S., Nomura Y., Tanaka N., Satake T., Saiki Y., Chen C.. Weitere Indan-1-on-Derivate der Gattung Pteris.. Chem. Pharm. Bull. 1976;24:1961–1964.
    doi: 10.1248/cpb.24.1961google scholar: lookup
  9. Kuroyanagi M., Fukuoka M., Yoshihira K., Natori S.. The Absolute Configurations of Pterosins, 1-Indanone Derivatives from Bracken, Pteridium aquilinum var. Latiusculum.. Chem. Pharm. Bull. 1974;22:723–726.
    doi: 10.1248/cpb.22.723google scholar: lookup
  10. Penberthy J.. Vegetable poisoning (?) simulating anthrax in cattle.. J. Comp. Pathol. Ther. 1893;6:266–275.
  11. Storrar D.. Cases of vegetable poisoning in cattle.. J. Comp. Pathol. Ther. 1893;6:276–279.
  12. Yoshihira K., Fukuoka M., Kuroyanagi M., Natori S., Umeda M., Morohoshi T., Enomoto M., Saito M.. Chemical and toxicological studies on bracken fern, Pteridium aquilinum var. latiusculum. I. Introduction, extraction and fractionation of constituents, and toxicological studies including carcinogenicity tests.. Chem. Pharm. Bull. 1978;26:2346–2364.
    doi: 10.1248/cpb.26.2346pubmed: 709696google scholar: lookup
  13. Cao H., Chai T.-T., Wang X., Morais-Braga M.F.B., Yang J.-H., Wong F.-C., Wang R., Yao H., Cao J., Cornara L.. Phytochemicals from fern species: Potential for medicine applications.. Phytochem. Rev. 2017;16:379–440.
    doi: 10.1007/s11101-016-9488-7pmc: PMC7089528pubmed: 32214919google scholar: lookup
  14. Harada T., Saiki Y.. Pharmaceutical Studies on Ferns. VIII. Distribution of Flavonoids in Ferns. (2). Pharm. Bull. 1955;3:469–472.
    doi: 10.1248/cpb1953.3.469pubmed: 13310212google scholar: lookup
  15. Wollenweber E.. Exudate flavonoids in ferns and their chemosystematic implication.. Biochem. Syst. Ecol. 1989;17:141–144.
  16. Giraud F., Bourhis M., Ebrahimi E., Herfindal L., Choudhury R.R., Bjørnstad R., Døskeland S.O., Anizon F., Moreau P.. Synthesis and activities of new indolopyrrolobenzodiazepine derivatives toward acute myeloid leukemia cells.. Bioorg. Med. Chem. 2015;23:7313–7323.
    doi: 10.1016/j.bmc.2015.10.031pubmed: 26526744google scholar: lookup
  17. Saito M., Umeda M., Enomoto M., Hatanaka Y., Natori S., Yoshihira K., Fukuoka M., Kuroyanagi M.. Cytotoxicity and carcinogenicity of pterosins and pterosides, 1-indanone derivatives from bracken (Pteridium aquilinum). Cell. Mol. Life Sci. 1975;31:829–831.
    doi: 10.1007/BF01938490pubmed: 1140326google scholar: lookup
  18. Hikino H., Miyase T., Takemoto T.. Biosynthesis of pteroside B in Pteridium aquilinum var. Latiusculum, proof of the sesquiterpenoid origin of the pterosides.. Phytochemistry 1976;15:121–123.
  19. McMorris T.C., Kelner M.J., Wang W., Estes L.A., Montoya M.A., Taetle R.. Structure-activity relationships of illudins: Analogs with improved therapeutic index.. J. Org. Chem. 1992;57:6876–6883.
    doi: 10.1021/jo00051a037google scholar: lookup
  20. Anchel M., Hervey A., Robbins W.J.. Antibiotic Substances from Basidiomycetes.. Proc. Natl. Acad. Sci. USA. 1950;36:300–305.
    doi: 10.1073/pnas.36.5.300pmc: PMC1063187pubmed: 15417544google scholar: lookup
  21. Kelner M.J., McMorris T.C., Beck W.T., Zamora J.M., Taetle R.. Preclinical evaluation of illudins as anticancer agents.. Cancer Res. 1987;47:3186–3189.
    pubmed: 3472654
  22. Liston D.R., Davis M.. Clinically Relevant Concentrations of Anticancer Drugs: A Guide for Nonclinical Studies.. Clin. Cancer Res. 2017;23:3489–3498.
  23. Nguyen X.H.T., Juvik O.J., Øvstedal D.O., Fossen T.. 6-Carboxydihydroresveratrol 3-O-β-glucopyranoside—A novel natural product from the Cretaceous relict Metasequoia glyptostroboides.. Fitoterapia 2014;95:109–114.
    doi: 10.1016/j.fitote.2014.03.001pubmed: 24631762google scholar: lookup
  24. Matsuo Y., MacLeod R., Uphoff C., Drexler H., Nishizaki C., Katayama Y., Kimura G., Fujii N., Omoto E., Harada M.. Two acute monocytic leukemia (AML-M5a) cell lines (MOLM-13 and MOLM-14) with interclonal phenotypic heterogeneity showing MLL-AF9 fusion resulting from an occult chromosome insertion, ins(11;9)(q23;p22p23). Leukemia 1997;11:1469–1477.
    doi: 10.1038/sj.leu.2400768pubmed: 9305600google scholar: lookup
  25. Oftedal L., Selheim F., Wahlsten M., Sivonen K., Døskeland S.O., Herfindal L.. Marine Benthic Cyanobacteria Contain Apoptosis-Inducing Activity Synergizing with Daunorubicin to Kill Leukemia Cells, but not Cardiomyocytes.. Mar. Drugs. 2010;8:2659–2672.
    doi: 10.3390/md8102659pmc: PMC2992999pubmed: 21116413google scholar: lookup
  26. Myhren L., Nilssen I.M., Nicolas V., Døskeland S.O., Barratt G., Herfindal L.. Efficacy of multi-functional liposomes containing daunorubicin and emetine for treatment of acute myeloid leukaemia.. Eur. J. Pharm. Biopharm. 2014;88:186–193.
    doi: 10.1016/j.ejpb.2014.04.002pubmed: 24747809google scholar: lookup
  27. Viktorsson E., Grøthe B.M., Aesoy R., Sabir M., Snellingen S., Prandina A., Åstrand O.A.H., Bonge-Hansen T., Døskeland S.O., Herfindal L.. Total synthesis and antileukemic evaluations of the phenazine 5,10-dioxide natural products iodinin, myxin and their derivatives.. Bioorganic Med. Chem. 2017;25:2285–2293.
    doi: 10.1016/j.bmc.2017.02.058pubmed: 28284865google scholar: lookup

Citations

This article has been cited 0 times.